ARTICLE | Clinical News
Agouron regulatory update
September 25, 1995 7:00 AM UTC
The San Diego company received notice of allowance for a U.S. Patent covering the chemical composition of its Viracept HIV protease inhibitor (AG1343). ...
The San Diego company received notice of allowance for a U.S. Patent covering the chemical composition of its Viracept HIV protease inhibitor (AG1343). ...